Latest news

See more
08 jan, 2019 Grifols receives FDA approval of Erytra Eflexis®, the latest advancement in scalable blood typing solutions
Read more

19 dec, 2018 Grifols partners with the Republic of Liberia to explore an innovative approach to combat Ebola virus disease
Read more

15 nov, 2018 Grifols introduces AlfaCare in Spain, the first support program for patients with Alpha-1 Antitrypsin Deficiency (AATD)
Read more

Media contacts

Journalist or media professional?

Our Media Relations team is available at:
(+34) 93 571 00 02
media@grifols.com
.
Restricted to media inquiries only.

Not a journalist?

For general questions and requests, please contact corporatecomms@grifols.com.